Difficulty: Medium
Average Score: 68%
Practice
The following is used in acromegaly & in hyperprolactinemia:
Correct answer
B
Rationale
In this NCLEX question on chemotherapy drugs, the correct answer is option B) Bromocriptine.
Bromocriptine is a dopamine agonist that is used in the treatment of acromegaly, a condition characterized by excessive growth hormone production, as well as in hyperprolactinemia, a condition marked by elevated levels of prolactin hormone.
Octreotide (option A) is a somatostatin analog primarily used in the treatment of acromegaly, but not in hyperprolactinemia. Nafarelin (option C) is a gonadotropin-releasing hormone agonist used in the treatment of endometriosis and central precocious puberty, not in acromegaly or hyperprolactinemia. Terlipressin (option D) is a vasopressin analog used in the management of hepatorenal syndrome and variceal bleeding, not in the conditions mentioned in the question.
Understanding the mechanisms of action and specific indications of each drug is crucial for nurses and healthcare professionals to provide safe and effective care to patients receiving chemotherapy. This question assesses the test-taker's knowledge of these specific chemotherapy drugs and their respective uses in acromegaly and hyperprolactinemia. Remembering these details is essential for making informed clinical decisions and optimizing patient outcomes.
Bromocriptine is a dopamine agonist that is used in the treatment of acromegaly, a condition characterized by excessive growth hormone production, as well as in hyperprolactinemia, a condition marked by elevated levels of prolactin hormone.
Octreotide (option A) is a somatostatin analog primarily used in the treatment of acromegaly, but not in hyperprolactinemia. Nafarelin (option C) is a gonadotropin-releasing hormone agonist used in the treatment of endometriosis and central precocious puberty, not in acromegaly or hyperprolactinemia. Terlipressin (option D) is a vasopressin analog used in the management of hepatorenal syndrome and variceal bleeding, not in the conditions mentioned in the question.
Understanding the mechanisms of action and specific indications of each drug is crucial for nurses and healthcare professionals to provide safe and effective care to patients receiving chemotherapy. This question assesses the test-taker's knowledge of these specific chemotherapy drugs and their respective uses in acromegaly and hyperprolactinemia. Remembering these details is essential for making informed clinical decisions and optimizing patient outcomes.